<DOC>
	<DOCNO>NCT01374880</DOCNO>
	<brief_summary>The objective work investigate sequence new biomarkers plasma patient present dyspnea secondary heart failure , study diagnostic prognostic value .</brief_summary>
	<brief_title>Diagnostic Prognostic Value New Biomarkers Patients With Heart Disease</brief_title>
	<detailed_description>Plasma sample patient dyspnea , edema , without heart failure ; ambulatory admit cardiac decompensation ( even cardiac shock LVAD ) ; enter cardiac rehabilitation program , prospectively collect . The objective work investigate sequence new protein plasma patient diagnostic prognostic purpose .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<criteria>Patients present shortness breath secondary heart failure , even cardiac shock LVAD . Patients valvular disease chronic stable heart failure . post partum Cardiomyopathy terminal cancer progressive neurological disease pregnancy opposition patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Heart disease</keyword>
	<keyword>Pulmonary disease</keyword>
	<keyword>Natriuretic peptide</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>